Summary of new percutaneous treatments for valve disease
| Technique | Current status |
| Mitral | |
| Balloon valvuloplasty | Clinical practice. Suitable for most pure stenosis |
| Edge-to-edge repair | Positive early human experience. Entering clinical trials |
| Coronary sinus annuloplasty | Experimental, few human cases performed |
| Aortic | |
| Balloon valvuloplasty | Clinical practice. Only suitable for congenital stenosis or as a palliative procedure |
| Percutaneous valve | Early human experience. Further development of device design will improve clinical results |
| Pulmonary | |
| Balloon valvuloplasty | Clinical practice. Suitable for congenital valvar stenosis |
| Bare stent | Clinical practice. Suitable for acquired conduit stenosis |
| Likely to be discarded in favour of percutaneous valve | |
| Percutaneous valve | Positive human experience. Entering clinical trials |
| Likely to become clinical practice in the near future | |
| Tricuspid | |
| Percutaneous valve | Experimental, clinical applications remote |
| Hybrid procedures combining percutaneous techniques with minimally invasive surgery are likely to become more popular | |